Avara Pharmaceutical Services
Private Company
Funding information not available
Overview
Avara is an established pharmaceutical contract manufacturing organization (CMO) with a global footprint, founded in 1999 and headquartered in Norman, Oklahoma. The company's core capabilities include oral solid dose (OSD) manufacturing, sterile fill-finish for liquids and lyophilized products, and integrated packaging, with a strong emphasis on handling potent compounds and meeting international regulatory standards. It operates former large-scale facilities from major pharma companies (Merck, Pfizer, Astellas), leveraging their legacy expertise to serve over 40 countries. As a private service provider, Avara's business model is built on long-term client partnerships and flexible, tailored manufacturing solutions.
Technology Platform
Integrated contract manufacturing platform for oral solid dose (including potent compounds), sterile fill-finish (liquid & lyophilized), and integrated packaging services. Utilizes legacy facilities from major pharma with global regulatory approvals.
Opportunities
Risk Factors
Competitive Landscape
Avara competes in the fragmented pharmaceutical CMO market against large global players (e.g., Lonza, Catalent, Thermo Fisher) and numerous specialized mid-sized and regional manufacturers. Its differentiation lies in its focus on legacy, proven facilities, handling of potent compounds, and a client-flexible approach within the oral solid dose and sterile fill-finish niches.